Dermal allograft is a technique used to treat and improve the damaged inner layer of skin called dermis. The dermal allograft is done from one person to another of similar species but with a different genotype. The dermal allograft is developed from human tissue or synthetic tissue or combinations of both. The dermal allograft is commonly used for burn injuries, acute & chronic wounds and for diabetic foot ulcers. Rising number of patients with diabetes and increasing demand for minimally invasive dermal allograft procedures, and the growth in ageing population are the major factors driving the market growth of the dermal allograft market. The dermal allograft has been indicated for preparation of wound bed, final dressing and sandwich grafting technique. Dermal allograft also used as temporary coverage after burn scar relief. The growth of the dermal allograft market is mainly attributed to increasing skin graft demand, novel product launch and the rising prevalence of skin related disorders such as skin cancer and melanoma. Moreover, the key manufacturer of dermal allograft market putting efforts to develop the innovative and new dermal allografts products and technique for various medical applications. This factor is expected to increase the global market growth of dermal allograft market in the forecast years.
According to the American Academy of Dermatology, in the US, skin cancer is the most common cancer affecting around 9.5 million population every day. The incidence of melanoma which is most common cancer in women increasing at a high rate than in men. According to the WHO (World Health Organization), over the past years, it has been observed the high growth of the incidence of melanoma and non-melanoma skin cancers. Presently, around three million non-melanoma skin cancers (NMSCs) and 130 million melanoma skin cancers reported globally each year. This growing incidence of skin cancer increasing demand for better skin treatment and innovative products which indirectly boosting the market growth of dermal allograft. However, the use of dermal allograft substitutes to reduce the problems associated with the use of dermal allografts may retrain the global dermal allograft market. Additionally, lack of expertise for dermal allograft, less clinical support and availability of cheap substitute products can also affect the market growth of dermal allograft in developing regions.
The global market for dermal allograft is segmented on basis of product type, end user and geography.
Dermal allograft is considered to be the fastest growing industry which provides a huge market opportunity for existing and new market players. For developing countries, dermal allograft technique is new technology which is gaining popularity from past few years. Dermal allograft is constantly being developed and improved. Dermal allograft represents an effective way of curing the skin injuries and wounds. Dermal allograft is able to protect the damaged skin dermis from contamination and fluid loss. Dermal allograft accelerates the wound healing process by releasing cytokines and growth factors at the wound site.
On the basis of geography, the global dermal allograft market is segmented into six key regions viz. North America, Latin America, Europe, the Asia Pacific excluding China, China and the Middle East & Africa. The North America dermal allograft market is expected to register the maximum market share in the global market, followed by Europe, due to increased health care spending on skin related surgeries, availability of skilled surgeons and better treatments. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period and is projected to be a profitable market for new emerging market players in the dermal allograft market owing to the availability of cheap substitute products. However, the market for dermal allograft in Latin America and the Middle East and Africa regions are estimated to show a stagnant growth over the forecast period.
Examples of some of the key players present in the global dermal allograft market are Integra Lifesciences Corporation, Smith & Nephew, Braun Melsungen AG, Zimmer Biomet, Mölnlycke Health Care, Medtronic, Organogenesis, Inc. and others.
The report covers exhaustive analysis on:
Regional analysis includes